Related Experiment Videos
TBJ murine neuroblastoma resists dibutyryl cyclic AMP-induced differentiation and effects on metalloproteinase
1Department of Surgery, LP Markey Cancer Center, University of Kentucky Medical Center, Lexington 40536, USA.
Background:
Nonmetastatic C1300 murine neuroblastoma and TBJ, a metastatic variant, exhibit different mechanisms of metastasis and invasion.
Methods:
In this study, they were examined for response to 1 mmol/L dibutyryl cyclic AMP in vitro.
Results:
(1) dCAMP induced morphological differentiation in 20% to 40% of C1300 cells, whereas TBJ resisted differentiation. (2) Untreated TBJ expressed 92-kDa metalloproteinase, whereas C1300 expressed none. These results were not affected by dCAMP. (3) Growth curves of untreated C1300 and TBJ were exponential. Dibutyryl CAMP induced a plateau in C1300 growth that was confirmed by increased S-phase cells by cell cycle analysis.
Conclusions:
TBJ growth was unaffected by dCAMP. Apoptosis, as assayed by Hoechst-merocyanine staining test, was not involved in the growth plateau.
Insights
Dibutyryl cyclic AMP (dCAMP) induced differentiation and growth arrest in nonmetastatic neuroblastoma cells but not in their metastatic variant. Metastatic TBJ cells expressed metalloproteinase, unlike nonmetastatic C1300 cells.
Area of Science:
- Neuroscience
- Cancer Biology
- Cellular Differentiation
Background:
- Nonmetastatic C1300 murine neuroblastoma and its metastatic variant, TBJ, display distinct metastasis and invasion mechanisms.
- Understanding these differences is crucial for targeted cancer therapies.
Purpose of the Study:
- To investigate the differential response of C1300 and TBJ cells to dibutyryl cyclic AMP (dCAMP).
- To elucidate the role of dCAMP in cellular differentiation, growth, and metalloproteinase expression in neuroblastoma models.
Main Methods:
- Exposure of C1300 and TBJ cells to 1 mmol/L dibutyryl cyclic AMP (dCAMP) in vitro.
- Assessment of morphological differentiation, cell growth kinetics, cell cycle progression, and metalloproteinase expression.
- Apoptosis was evaluated using Hoechst-merocyanine staining.
Main Results:
- dCAMP induced morphological differentiation in 20-40% of C1300 cells, while TBJ cells resisted differentiation.
- Untreated TBJ cells expressed 92-kDa metalloproteinase, whereas C1300 cells did not; dCAMP did not alter this expression.
- dCAMP induced a growth plateau in C1300 cells, evidenced by increased S-phase cells, but did not affect TBJ growth.
Conclusions:
- TBJ cells, a metastatic neuroblastoma variant, are resistant to dCAMP-induced differentiation and growth arrest.
- Metalloproteinase expression in TBJ cells is independent of dCAMP treatment.
- Apoptosis does not mediate the growth plateau observed in C1300 cells upon dCAMP treatment.